Intraperitoneal chemotherapy of ovarian cancer: a review, with a focus on practical aspects of treatment.
Markman
Maurie
M
The University of Texas M.D. Anderson Cancer Center, Houston, TX 77030, USA. mmarkman@mdanderson.org
Walker
Joan L
JL
D000970:Antineoplastic Agents / Q000008:administration & dosage* / Q000009:adverse effects; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D017326:Clinical Trials, Phase III as Topic; D005260:Female; D006801:Humans; D007263:Infusions, Parenteral / Q000009:adverse effects; D010051:Ovarian Neoplasms / Q000188:drug therapy* / Q000473:pathology / Q000601:surgery; D017239:Paclitaxel / Q000008:administration & dosage
D000970:Antineoplastic Agents; D016190:Carboplatin; D017239:Paclitaxel; D002945:Cisplatin